They could perhaps see sustained runs beyond this year.

Swiss-American biotechnology company, CRISPR Therapeutics AG (NASDAQ: CRSP), has come under renewed pressure in recent weeks, ...

Delve into what 2026 has to offer in the biotech industry. The market is showing signs it's picking up and the patent cliff ...

China quietly became biotech’s back-office, from molecule synthesis and clinical trials to novel drug licensing. Now the ...

Explore how leadership in biotech drives success through a milestone approach, aligning teams and culture from science to ...

Biotech headwinds are driving double-digit revenue growth and profitability for these two mid-caps.

For biotech companies the past two years have been challenging. Biotech investments have not reached the record levels of ...

A life sciences hub in Syracuse is getting a major upgrade as New York pushes to grow its biotechnology sector. Gov. Kathy Hochul announced Monday that the state will invest nearly $3 million to ...

Department of Economic & Community Development Commissioner Daniel O'Keefe speaks at the BioCT legislative breakfast in New ...

Learn how LABD delivers -3x daily biotech exposure, why it’s down 99.98% since inception, and when it fits short-term trades.

The biotech sector is one that’s become red-hot, at least in recent years. After around a decade of stagnation, investors ...

At some point in your research career, you may find yourself transitioning from academia to industry or vice versa. To best set yourself up for success, adapt your approach to the specific scientific ...